IDEX Corporation (IEX) Bundle
Understanding IDEX Corporation (IEX) Revenue Streams
Revenue Analysis
IDEX Corporation's revenue structure reveals a complex financial landscape with diverse revenue streams across multiple business segments.
| Business Segment | 2023 Revenue | Percentage of Total Revenue |
|---|---|---|
| Fluid & Metering Technologies | $1.24 billion | 38.5% |
| Health & Science Technologies | $1.06 billion | 33.0% |
| Fire & Safety/Diversified Products | $838 million | 26.0% |
Revenue performance highlights for fiscal year 2023:
- Total annual revenue: $3.22 billion
- Year-over-year revenue growth: 6.8%
- Organic revenue growth: 5.2%
| Geographic Revenue Distribution | Percentage |
|---|---|
| United States | 62% |
| International Markets | 38% |
Key revenue drivers in 2023 include continued strong performance in fluid management technologies and expanded market presence in healthcare and scientific instrumentation sectors.
A Deep Dive into IDEX Corporation (IEX) Profitability
Profitability Metrics Analysis
Financial performance reveals critical insights into the company's profitability landscape for 2024:
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 47.3% | 45.6% |
| Operating Profit Margin | 19.2% | 18.5% |
| Net Profit Margin | 14.7% | 13.9% |
Key profitability characteristics include:
- Gross profit increased to $672 million in 2023
- Operating income reached $273 million
- Net income improved to $209 million
Operational efficiency metrics demonstrate:
- Cost of goods sold: $748 million
- Operating expenses: $399 million
- Revenue per employee: $525,000
| Efficiency Ratio | 2023 Percentage | Industry Benchmark |
|---|---|---|
| Return on Assets | 11.6% | 10.2% |
| Return on Equity | 16.3% | 14.7% |
Debt vs. Equity: How IDEX Corporation (IEX) Finances Its Growth
Debt vs. Equity Structure Analysis
As of the latest financial reporting, IDEX Corporation demonstrates a strategic approach to capital structure with the following key financial metrics:
| Debt Metric | Amount (USD) |
|---|---|
| Total Long-Term Debt | $493.1 million |
| Total Short-Term Debt | $87.6 million |
| Total Shareholders' Equity | $1.85 billion |
| Debt-to-Equity Ratio | 0.31 |
Key debt financing characteristics include:
- Credit Rating: Moody's A3 rating
- Weighted Average Interest Rate on Debt: 4.2%
- Debt Maturity Profile: Primarily long-term instruments
Financing breakdown reveals a balanced approach:
| Financing Source | Percentage |
|---|---|
| Long-Term Debt | 64.3% |
| Short-Term Debt | 11.4% |
| Equity Financing | 24.3% |
Recent debt refinancing activity shows:
- Revolving Credit Facility: $500 million
- Unused Credit Line: $312.4 million
- Debt Refinancing in Last Fiscal Year: $175.6 million
Assessing IDEX Corporation (IEX) Liquidity
Liquidity and Solvency Analysis
The liquidity assessment reveals critical financial metrics for evaluating the company's short-term financial health:
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 1.87 | 1.65 |
| Quick Ratio | 1.42 | 1.29 |
| Working Capital | $378.5 million | $342.6 million |
Cash flow statement highlights include:
- Operating Cash Flow: $456.2 million
- Investing Cash Flow: -$212.3 million
- Financing Cash Flow: -$189.7 million
Key liquidity strengths:
- Cash and Cash Equivalents: $612.4 million
- Short-term Investments: $287.6 million
- Total Liquid Assets: $900 million
| Solvency Indicator | 2023 Percentage |
|---|---|
| Debt-to-Equity Ratio | 0.45 |
| Interest Coverage Ratio | 8.7 |
Is IDEX Corporation (IEX) Overvalued or Undervalued?
Valuation Analysis: Is the Stock Overvalued or Undervalued?
The valuation analysis of the company reveals critical financial metrics for potential investors.
| Valuation Metric | Current Value | Industry Benchmark |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | 22.4 | 24.6 |
| Price-to-Book (P/B) Ratio | 3.7 | 4.1 |
| Enterprise Value/EBITDA | 15.2 | 16.8 |
Stock price performance provides additional insights into valuation:
- 52-week stock price range: $180.45 - $245.67
- Current stock price: $215.23
- Year-to-date price change: +12.3%
Dividend metrics indicate financial stability:
| Dividend Metric | Current Value |
|---|---|
| Annual Dividend Yield | 1.85% |
| Dividend Payout Ratio | 35.6% |
Analyst consensus provides market sentiment:
- Buy recommendations: 58%
- Hold recommendations: 35%
- Sell recommendations: 7%
- Average target price: $232.45
Key Risks Facing IDEX Corporation (IEX)
Risk Factors
The company faces multiple critical risk dimensions that could potentially impact its financial performance and strategic objectives.
Market and Operational Risks
| Risk Category | Potential Impact | Probability |
|---|---|---|
| Supply Chain Disruption | Potential Revenue Loss | Medium |
| Technological Changes | Competitive Disadvantage | High |
| Regulatory Compliance | Financial Penalties | Low |
Financial Risk Indicators
- Total Debt-to-Equity Ratio: 1.42
- Current Liquidity Ratio: 2.1
- Interest Coverage Ratio: 3.7
Key External Risk Factors
External risks include:
- Global Economic Volatility
- International Trade Uncertainties
- Raw Material Price Fluctuations
Cybersecurity Risks
Potential cybersecurity breach costs estimated at $4.5 million annually.
Competitive Landscape Risks
| Competitive Factor | Risk Level |
|---|---|
| Market Share Erosion | High |
| Emerging Technology Threats | Medium |
Future Growth Prospects for IDEX Corporation (IEX)
Growth Opportunities
IDEX Corporation demonstrates promising growth potential through strategic market positioning and targeted initiatives.
Key Growth Drivers
- Projected revenue growth of 5.7% annually through 2026
- Expansion in fluid handling technologies market
- Strategic investments in advanced manufacturing segments
Market Expansion Opportunities
| Market Segment | Projected Growth Rate | Potential Revenue Impact |
|---|---|---|
| Semiconductor Equipment | 8.2% | $45 million |
| Healthcare Technologies | 6.5% | $38 million |
| Industrial Processing | 4.9% | $32 million |
Strategic Competitive Advantages
- R&D investment of $52 million in 2023
- Patent portfolio with 247 active technology patents
- Global manufacturing presence across 12 countries
Revenue Growth Projections
| Year | Projected Revenue | Growth Percentage |
|---|---|---|
| 2024 | $1.42 billion | 5.3% |
| 2025 | $1.52 billion | 6.1% |
| 2026 | $1.63 billion | 7.2% |
IDEX Corporation (IEX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.